Current Issue

Original research

• Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study (4 November, 2022)

  Marios C Pantzaris, Christos Bakirtzis, Nikolaos Grigoriadis, Georgios Hadjigeorgiou, Efthimos Dardiotis, George Loucaides, Evangelia Ntzani, Georgios Markozannes, Savvas Omorfos, Paola Valsasina, Roberta Messina, Paolo Preziosa, Maria A Rocca, Ioannis Patrikios
• Cortisol, cognition and Alzheimer’s disease biomarkers among memory clinic patients (19 October, 2022)

  Jasper Holleman, Sofia Adagunodo, Ingemar Kåreholt, Göran Hagman, Malin Aspö, Chinedu T Udeh-Momoh, Alina Solomon, Miia Kivipelto, Shireen Sindi
• Circle of Willis variation and outcome after intra-arterial treatment (20 September, 2022)

  Anouk Rozeman, Hajo Hund, Jelis Boiten, Jan-Albert Vos, Wouter Schonewille, Marieke Wermer, Geert Lycklama a Nijeholt, Ale Algra
• Practical utility of the ACT-FAST triage algorithm from a primary stroke centre perspective (8 September, 2022)

  Shuangyue Tan, Karen Stephens, Lan Gao, Elise Tan, Tanya Frost, Philip M C Choi
• Survey of healthcare professionals’ knowledge, attitudes and practices regarding spontaneous intracranial hypotension (5 September, 2022)

  Sanjay Cheema, Jane Anderson, Callum Duncan, Indran Davagnanam, Paul Armstrong, Nancy Redfern, Anthony Ordman, Linda D’Antona, Justin Nissen, Parag Sayal, Eyston Vaughan-Huxley, Susie Lagrata, Valeria Iodice, Jessica Snape-Burns, Clare Joy, Manjit Matharu
• Efficacy of botulinum toxin type a in the targeted treatment of sleep bruxism: a double-blind, randomised, placebo-controlled, cross-over study (5 September, 2022)

  Belinda Cruse, Thanuja Dharmadasa, Elise White, Callum Hollis, Andrew Evans, Sifat Sharmin, Tomas Kalincik, Lynette Kiers
• Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts (5 September, 2022)

  Greta K Wood, Roshan Babar, Mark A Ellul, Rhys Huw Thomas, Harriet Van Den Tooren, Ava Easton, Kukatharmini Tharmaratnam, Girvan Burnside, Ali M Alam, Hannah Castell, Sarah Boardman, Ceryce Collie, Bethany Facer, Cordelia Dunai, Sylviane Defres, Julia Granerod, David W G Brown, Angela Vincent, Anthony Guy Marson, Sarosh R Irani, Tom Solomon, Benedict D Michael
• Nationwide survey of Lambert-Eaton myasthenic syndrome in Japan (5 September, 2022)

  Hiroaki Yoshikawa, Yumi Adachi, Yosikazu Nakamura, Nagato Kuriyama, Hiroyuki Murai, Yoshiko Nomura, Yasunari Sakai, Kazuo Iwasa, Yutaka Furukawa, Satoshi Kuwabara, Makoto Matsui
• Dementia clinical trials over the past decade: are women fairly represented? (5 September, 2022)

  Ana-Catarina Pinho-Gomes, Jessica Gong, Katie Harris, Mark Woodward, Cheryl Carcel
• Prediction modelling the impact of onset to treatment time on the modified Rankin Scale score at 90 days for patients with acute ischaemic stroke (16 August, 2022)

  Nicklas Ennab Vogel, Turgut Tatlisumak, Per Wester, Johan Lyth, Lars-Åke Levin
• Different AT(N) profiles and clinical progression classified by two different N markers using total tau and neurofilament light chain in cerebrospinal fluid (10 August, 2022)

  Kensaku Kasuga, Masataka Kikuchi, Tamao Tsukie, Kazushi Suzuki, Ryoko Ihara, Atsushi Iwata, Norikazu Hara, Akinori Miyashita, Ryozo Kuwano, Takeshi Iwatsubo, Takeshi Ikeuchi
• Serum IgG levels to Epstein-Barr and measles viruses in patients with multiple sclerosis during natalizumab and interferon beta treatment (27 July, 2022)

  Linn Persson Berg, Marcus Eriksson, Sonia Longhi, Ingrid Kockum, Clemens Warnke, Elisabeth Thomsson, Malin Bäckström, Tomas Olsson, Anna Fogdell-Hahn, Tomas Bergström
• Direct delivery of an investigational cell therapy in patients with Parkinson’s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design (15 July, 2022)

  Jorge E Quintero, John T Slevin, Julie A Gurwell, Christopher J McLouth, Riham El Khouli, Monica J Chau, Zain Guduru, Greg A Gerhardt, Craig G van Horne
• Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study (12 July, 2022)

  Arina A Tamborska, Bhagteshwar Singh, Sonja E Leonhard, Eva Maria Hodel, Julia Stowe, Taylor Watson-Fargie, Peter M Fernandes, Andreas C Themistocleous, Jacob Roelofs, Kathryn Brennan, Caroline Morrice, Benedict D Michael, Bart C Jacobs, Helen McDonald, Tom Solomon
• Large vessel occlusion prediction scales provide high negative but low positive predictive values in prehospital suspected stroke patients (11 July, 2022)

  Kevin J Keenan, Wade S Smith, Sara B Cole, Christine Martin, J Claude Hemphill, Debbie Y Madhok
• Treatment satisfaction in patients with relapsing-remitting multiple sclerosis initiated on teriflunomide in routine clinical practice: Australian observational data (4 July, 2022)

  Todd A Hardy, John Parratt, Heidi Beadnall, Stefan Blum, Richard Macdonell, Roy G Beran, Neil Shuey, Andrew Lee, William Carroll, Cameron Shaw, Richard Worrell, Jana Moody, Mamdouh Sedhom, Michael Barnett, Steve Vucic